Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13425-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13425-1-AP, RRID:AB_2097273
- Product name
- E2F8 antibody
- Antibody type
- Polyclonal
- Description
- E2F8 antibody (Cat. #13425-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Molecular mechanism underlying miR-204-5p regulation of adipose-derived stem cells differentiation into cells from three germ layers.
Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells.
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma.
HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
Wang Z, Bi M, Zhe X, Wang X, Dai B, Han X, Ren B, Liang H, Liu D
Cell death discovery 2024 Feb 22;10(1):95
Cell death discovery 2024 Feb 22;10(1):95
Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
Kong J, Xu S, Zhang P, Wang Y
International journal of toxicology 2023 Sep-Oct;42(5):420-429
International journal of toxicology 2023 Sep-Oct;42(5):420-429
Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells.
Hawkins CC, Jones AB, Gordon ER, Harsh Y, Ziebro JK, Willey CD, Griguer C, Crossman DK, Cooper SJ, Ramanadham S, Doan N, Hjelmeland AB
Cell death discovery 2023 Dec 12;9(1):451
Cell death discovery 2023 Dec 12;9(1):451
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma.
Feng X, Guo J, An G, Wu Y, Liu Z, Meng B, He N, Zhao X, Chen S, Zhu Y, Xia J, Li X, Yu Z, Li R, Ren G, Chen J, Wu M, He Y, Qiu L, Zhou J, Zhou W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2022 Mar;9(9):e2104491
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2022 Mar;9(9):e2104491
HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
Chen Y, Zhao F, Cui D, Jiang R, Chen J, Huang Q, Shi J
International journal of cancer 2018 Jun 1;142(11):2313-2322
International journal of cancer 2018 Jun 1;142(11):2313-2322
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The E2F8 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human E2F8. This antibody recognizes human, mouse, rat antigen. The E2F8 antibody has been validated for the following applications: ELISA, WB analysis.
